That is interesting, we would have to examine each fight on why that is.
Essential The Official MMA Thread
- Thread starter Wavydowneyjr
- Start date
Personally I want part 3 but I’m getting the feeling cormier is done with jones.
Forget gust
Screwface Exchange
All Star
Also remember styles makes fight. Weisman still solid in the ground. Him vs bones he isn't afraid of the wrestling aspect as he's a solid wrestler and prolly has bjj skills than Jones.
And yes Jones is a dangerous striker but not really a 1 shot ko kinda guy. I would buy weidman vs Jones more than Smith. Like really dis who is headli ING against the goat*
And yes Jones is a dangerous striker but not really a 1 shot ko kinda guy. I would buy weidman vs Jones more than Smith. Like really dis who is headli ING against the goat*
Bones is too big for him, weidman built his career on beating smaller fighters. He lost his edge when they changed the testing
Conor/Aldo didn't involve anyone moving up or down
Dope promo but gotta deal with the reality that this isn't that Silva anymore. Recently rewatched the Bisping/Silva fight and Bisping had Silva all out of sorts using basic ass feints and jabs, Adesanya gonna have Silva's head spinning.
storyteller
Veteran
There was Rory vs Gegard at least. That's the one example where the bigger fighter just completely controlled the fight that I can come up with in recent champ vs champ fights. Horguchi got the submission in the third but Green's size gave him trouble in their champ vs champ fight (I'm considering Guch a 125'er here). I think it's too limited to say too much so far, but definitely something we should keep an eye on. Going back; Penn/Hughes, GSP/Bisping, Conor/Eddie (technically) all fit the bill and I'd consider might adding Couture/Sylvia but that's a bit of a reach.
UFC light heavyweight champion Jon Jones hasn’t gotten rid of the steroid metabolite that upended his career.
Jones, 31, tested positive once for the long-term M3 metabolite of oral turinabol, according to drug tests administered by the Voluntary Anti-Doping Agency. The results were released Wednesday by the California State Athletic Commission after a public records request from MMAjunkie.
Jones’ Dec. 28 test had 33 picograms of the M3 metabolite of oral turinabol; his Dec. 29 test came back negative. According to CSAC executive director Andy Foster, Jones had an undisclosed number of additional tests this month that have turned up negative.
The World Anti-Doping agency-approved laboratory that processed his samples certified they weren’t performance-enhancing, according to Foster, who made clear the CSAC has no plan to discipline Jones.
Jones’ latest drug test results appear to back the conclusion of the U.S. Anti-Doping Agency, which determined the metabolite found prior to UFC 232 was a residual amount from the same one that resulted in a 15-month suspension.
Experts consulted by USADA and the UFC concluded the positive test – later revealed to be one of several positive and negative results since this past August – was the result of a “pulsing effect” of the metabolite, which theoretically could stay in Jones’ body indefinitely.
The latest samples come from Jones’ enrollment with VADA, which was ordered by the CSAC after a Dec. 9 drug test revealed trace amounts of the M3 metabolite. As MMAjunkie previously reported, Jones is subject to VADA testing for three to six months at a cost of $22,000 to the CSAC.
Jones, who’s also subject to out-of-competition testing by USADA, previously had tested positive on two occasions for similarly low levels while also passing five tests between August and November of 2018.
After the Dec. 9 test came back positive, Jones was immediately ordered to take a drug test and passed, prompting the CSAC to greenlight his title fight with Alexander Gustafsson at UFC 232.
Originally, the pay-per-view event was to take place at T-Mobile Arena in Las Vegas under the supervision of the Nevada State Athletic Commission. But the NSAC wouldn’t administratively clear Jones to fight, and it couldn’t convene a hearing soon enough to address the issue. Because Jones already had received a temporary license to fight in California, the UFC chose to move the entire event to The Forum in Inglewood, Calif.
Jones (23-1 MMA, 17-1 UFC) went on to stop Gustafsson in the third round, claiming the light heavyweight title relinquished by Daniel Cormier. Jones’ adverse test – first called “abnormal” by USADA – prompted a wave of criticism from observers, fans and fighters, including from Gustafsson and Jones’ rival Cormier.
Jones steadfastly has denied knowingly taking any performance-enhancing drugs and has vowed to rebuild his reputation with fans. Cormier (23-1 MMA, 17-1 UFC) recently questioned whether fighting Jones will forever carry the possibility of facing an opponent with an illegal steroid metabolite in his system. Gustafsson’s rep has blasted the decision to clear Jones and questioned his test results.
Jones is expected to go before the NSAC this month to discuss his Dec. 9 test “to determine the appropriate path forward for him in Nevada,” the NSAC said.
The champ reveled in a negative test found two weeks after his fight at UFC 232. He is expected to defend his title against Anthony Smith(31-13 MMA, 7-3 UFC) at UFC 235, which takes place March 2 at T-Mobile Arena in Las Vegas.
Jones, 31, tested positive once for the long-term M3 metabolite of oral turinabol, according to drug tests administered by the Voluntary Anti-Doping Agency. The results were released Wednesday by the California State Athletic Commission after a public records request from MMAjunkie.
Jones’ Dec. 28 test had 33 picograms of the M3 metabolite of oral turinabol; his Dec. 29 test came back negative. According to CSAC executive director Andy Foster, Jones had an undisclosed number of additional tests this month that have turned up negative.
The World Anti-Doping agency-approved laboratory that processed his samples certified they weren’t performance-enhancing, according to Foster, who made clear the CSAC has no plan to discipline Jones.
Jones’ latest drug test results appear to back the conclusion of the U.S. Anti-Doping Agency, which determined the metabolite found prior to UFC 232 was a residual amount from the same one that resulted in a 15-month suspension.
Experts consulted by USADA and the UFC concluded the positive test – later revealed to be one of several positive and negative results since this past August – was the result of a “pulsing effect” of the metabolite, which theoretically could stay in Jones’ body indefinitely.
The latest samples come from Jones’ enrollment with VADA, which was ordered by the CSAC after a Dec. 9 drug test revealed trace amounts of the M3 metabolite. As MMAjunkie previously reported, Jones is subject to VADA testing for three to six months at a cost of $22,000 to the CSAC.
Jones, who’s also subject to out-of-competition testing by USADA, previously had tested positive on two occasions for similarly low levels while also passing five tests between August and November of 2018.
After the Dec. 9 test came back positive, Jones was immediately ordered to take a drug test and passed, prompting the CSAC to greenlight his title fight with Alexander Gustafsson at UFC 232.
Originally, the pay-per-view event was to take place at T-Mobile Arena in Las Vegas under the supervision of the Nevada State Athletic Commission. But the NSAC wouldn’t administratively clear Jones to fight, and it couldn’t convene a hearing soon enough to address the issue. Because Jones already had received a temporary license to fight in California, the UFC chose to move the entire event to The Forum in Inglewood, Calif.
Jones (23-1 MMA, 17-1 UFC) went on to stop Gustafsson in the third round, claiming the light heavyweight title relinquished by Daniel Cormier. Jones’ adverse test – first called “abnormal” by USADA – prompted a wave of criticism from observers, fans and fighters, including from Gustafsson and Jones’ rival Cormier.
Jones steadfastly has denied knowingly taking any performance-enhancing drugs and has vowed to rebuild his reputation with fans. Cormier (23-1 MMA, 17-1 UFC) recently questioned whether fighting Jones will forever carry the possibility of facing an opponent with an illegal steroid metabolite in his system. Gustafsson’s rep has blasted the decision to clear Jones and questioned his test results.
Jones is expected to go before the NSAC this month to discuss his Dec. 9 test “to determine the appropriate path forward for him in Nevada,” the NSAC said.
The champ reveled in a negative test found two weeks after his fight at UFC 232. He is expected to defend his title against Anthony Smith(31-13 MMA, 7-3 UFC) at UFC 235, which takes place March 2 at T-Mobile Arena in Las Vegas.
No, but everyone acts like donor was a giant at 5'9 to shyt on him. Meanwhile Holloway and Ortega cut from 180-185.
It is the passing of the torch at 185. My all time favorite fighter vs one of my new favorite fighters.
People talk like that because of Conir himself, he made that cut look like death and is always talking about moving up. Ortega looks huge but seems to make that weight easily and looks like he could drop even more weight. Holloway until recently would y’all about “being a big Samoan” but didn’t used to have such a obvious hard time doing it.
We’re still only what? 2 years into the IV ban and other regulations...this is a transitional phase
Ortega and max will be at 155 soon enough. They are just as big as conor was. But as you get older you're body doesn't cut like it used to, it get hard on you. Conor could've made 145 for a while but there were no more fights at that weight for him after destroying aldo. He couldn't after fighting nate at 170 though. Bulked up to much. I mean he could but it would be a near death cut. Ortega could not go to 135 to dillashaw didn't even look good at 125.
